Retractable Technologies, Inc.  

(Public, NYSEAMERICAN:RVP)   Watch this stock  
Find more results for RVP
+0.012 (1.71%)
Jan 19 - Close
NYSEAMERICAN real-time data - Disclaimer
Currency in USD
Range 0.69 - 0.73
52 week 0.54 - 1.48
Open 0.69
Vol / Avg. 119,288.00/381,536.00
Mkt cap 23.26M
P/E     -
Div/yield     -
EPS -0.17
Shares 32.67M
Beta 0.41
Inst. own 10%
Apr 2, 2018
Q4 2017 Retractable Technologies Inc Earnings Release (Estimated) Add to calendar
Nov 14, 2017
Q3 2017 Retractable Technologies Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -0.64% -12.39%
Operating margin -0.32% -11.76%
EBITD margin - -7.30%
Return on average assets -0.67% -9.12%
Return on average equity -3.58% -15.35%
Employees 134 -
CDP Score - -


511 Lobo Ln
LITTLE ELM, TX 75068-5295
United States - Map
+1-972-2941010 (Phone)
+1-972-2923600 (Fax)

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Retractable Technologies, Inc. designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe. It also sells the VanishPoint intravenous catheter, the VanishPoint blood collection tube holder and the VanishPoint blood collection set. The PatientSafe syringe reduces the risk of bloodstream infections resulting from catheter hub contamination. Its PatientSafe products include 3mL, 5mL, 10mL, 20mL, 30mL and 60mL syringes, and the PatientSafe Luer cap. Its product designs include retractable needle syringe designs, retractable needle designs and retractable needle dental syringe designs.

Officers and directors

Thomas J. Shaw Chairman of the Board, President, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Douglas W. Cowan Chief Financial Officer, Vice President, Principal Accounting Officer, Treasurer, Director
Age: 73
Bio & Compensation  - Reuters
Michele M. Larios Vice President, General Counsel, Secretary
Age: 49
Bio & Compensation  - Reuters
Russell B. Kuhlman Vice President, Sales Development
Age: 62
Bio & Compensation  - Reuters
Walter O. Bigby Jr. Independent Director
Age: 50
Bio & Compensation  - Reuters
Marco Laterza Independent Director
Age: 68
Bio & Compensation  - Reuters
Amy Mack Independent Director
Age: 48
Bio & Compensation  - Reuters